Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Mar 29;103(6):972–981. doi: 10.3324/haematol.2017.182303

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2018 Ferrata Storti Foundation

Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions:

https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions:

https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher.

PMC Copyright notice

Figure 3. — Increased adhesion to laminin of red blood cells (RBCs) from hydroxycarbamide (HC)-treated patients. (A) Adhesion to laminin at 3 dyn/cm² of RBCs from 11 control (CT), 17 untreated (UT), 16 HC-treated (HC) and 11 IFN-treated (IFN) polycythemia vera patients. Horizontal lines represent medians. (B) The JAK2V617F allele burden (%JAK2V617F). RBC adhesion as a function of (C) %JAK2V617F (R²=0.048) and (D) Lu/BCAM mean fluorescence intensity (MFI) (R²=0.67) for 16 HC-treated patients.